Rodent carcinogenicity of peroxisome proliferators and issues on human relevance

被引:43
作者
Lai, DY [1 ]
机构
[1] US EPA, Off Pollut Prevent & Tox, Risk Assessment Div, Washington, DC 20460 USA
关键词
peroxisome proliferators; PPAR alpha; hepatocarcinogenesis; human relevance;
D O I
10.1081/GNC-120038005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A variety of substances such as hypolipidemic drugs, phthalate ester plasticizers, pesticides, and industrial solvents have been shown to increase the size and number of peroxisomes in rats and mice. They are grouped under the generic term peroxisome proliferators (PP) because of their unique property of inducing peroxisome proliferation. There are marked species differences in response to PP. Rats and mice are most sensitive, and banisters show an intermediate response while guinea pigs, monkeys, and humans appear to be relatively insensitive or non-responsive at dose levels that produce a marked response in rodents. Out of over 100 PP identified to date, about 30 have been adequately tested and shown to be carcinogenic, inducing tumors (primarily in the liver) upon chronic administration to rats and/or mice; hence, chemicals which induce the proliferation of peroxisomes have formed a unique class of chemical carcinogens. It is now well documented that activation of the "peroxisome proliferator-activated receptor alpha" (PPARalpha) is involved in PP-induced liver growth and carcinogenesis in rodents. PPARalpha is also present in human cells; however, the levels reported are about 10% of those found in the liver of rodents. The human relevance of rodent tumors induced by PP has been the subject of debate over the last decade. Review of the existing evidence on PPAR-alpha agonists by a recent International Life Science Institute (ILSI) workgroup following a human relevance mode of action (MOA) framework has concluded that despite the presence of similar pathways in humans, it is unlikely that the proposed MOA for rodent tumors is plausible in humans, taking into account kinetic and dynamic factors. The data, however, did not permit a definitive conclusion that the animal MOA is not plausible in humans. While these agents appear unlikely to be hepatocarcinogens in humans at expected levels of human exposure, it remains uncertain to some experts in the field whether there is no possibility of carcinogenic potential under any circumstance of PP exposure, and if the potential human carcinogenicity of these chemicals can be summarily ignored. A number of remaining issues on human relevance of rodent tumors induced by PP are discussed.
引用
收藏
页码:37 / 55
页数:19
相关论文
共 61 条
[1]  
[Anonymous], BR MED J
[2]   MECHANISTICALLY-BASED HUMAN HAZARD ASSESSMENT OF PEROXISOME PROLIFERATOR-INDUCED HEPATOCARCINOGENESIS [J].
ASHBY, J ;
BRADY, A ;
ELCOMBE, CR ;
ELLIOTT, BM ;
ISHMAEL, J ;
ODUM, J ;
TUGWOOD, JD ;
KETTLE, S ;
PURCHASE, IFH .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1994, 13 :S1-S117
[3]   Oncogenicity testing of 2-ethylhexanol in Fischer 344 rats and B6C3F1 mice [J].
Astill, BD ;
Gingell, R ;
Guest, D ;
Hellwig, J ;
Hodgson, JR ;
Kuettler, K ;
Mellert, W ;
Murphy, SR ;
Sielken, RL ;
Tyler, TR .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1996, 31 (01) :29-41
[4]   HEPATIC PEROXISOME PROLIFERATION IN RODENTS AND ITS SIGNIFICANCE FOR HUMANS [J].
BENTLEY, P ;
CALDER, I ;
ELCOMBE, C ;
GRASSO, P ;
STRINGER, D ;
WIEGAND, HJ .
FOOD AND CHEMICAL TOXICOLOGY, 1993, 31 (11) :857-907
[5]   Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats [J].
Biegel, LB ;
Hurtt, ME ;
Frame, SR ;
O'Connor, JC ;
Cook, JC .
TOXICOLOGICAL SCIENCES, 2001, 60 (01) :44-55
[6]  
BUTALA JH, 1997, TOXICOLOGIST, V36, P173
[7]   Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? [J].
Cattley, RC ;
DeLuca, J ;
Elcombe, C ;
Fenner-Crisp, P ;
Lake, BG ;
Marsman, DS ;
Pastoor, TA ;
Popp, JA ;
Robinson, DE ;
Schwetz, B ;
Tugwood, J ;
Wahli, W .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 27 (01) :47-60
[8]  
COHEN SM, 2003, OVERVIEW, V33, P581
[9]   INDUCTION OF LEYDIG-CELL ADENOMAS BY AMMONIUM PERFLUOROOCTANOATE - A POSSIBLE ENDOCRINE-RELATED MECHANISM [J].
COOK, JC ;
MURRAY, SM ;
FRAME, SR ;
HURTT, ME .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 113 (02) :209-217
[10]   Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators [J].
Corton, JC ;
Lapinskas, PJ ;
Gonzalez, FJ .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 448 (02) :139-151